Evidence map›Paper›PMID 29930863›Full record

ArticleAcute medicine & surgery2014

Emergence of third-generation cephalosporin-resistant

Hideharu Hagiya, Tomoko Murase, Masato Suzuki, Fumio Otsuka, Keigo Shibayama

Abstract read
In one paragraph

Article in Acute medicine & surgery, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hideharu HagiyaDepartment of General Medicine Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science Okayama Japan.
Tomoko MuraseDepartment of Clinical Laboratory, Microbiology Division Tsuyama Central Hospital Okayama Japan.
Masato SuzukiDepartment of Bacteriology II National Institute of Infectious Diseases Tokyo Japan.
Fumio OtsukaDepartment of General Medicine Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science Okayama Japan.
Keigo ShibayamaDepartment of Bacteriology II National Institute of Infectious Diseases Tokyo Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimExtended-spectrum beta-lactamases and AmpC beta-lactamases give resistance to

methodsA review of patients' clinical data, pulsed-field gel electrophoresis epidemiological study against the strains, and polymerase chain reaction analysis for the detection of extended-spectrum beta-lactamase genes (

resultsPulsed-field gel electrophoresis showed none of the subjects were genetically identical organisms. However, all strains possessed either extended-spectrum beta-lactamases (

conclusionThis study revealed that various types of easily transmittable drug resistance genes exist in the critical care setting concurrently. This case was not an outbreak of such strains, but the present situation might indicate a more serious condition than a mere outbreak of a single resistant strain.

Indexed as

AmpC beta‐lactamases (AmpC‐BLs)Citrobacter freundiiextended‐spectrum beta‐lactamases (ESBLs)intensive care unit (ICU)outbreak

Identifiers

PMID29930863
PMCPMC5997195

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.